HEALING, EMPOWERMENT AND INSPIRATION - FOR YOU!
| ||||||||||||||||||||||||||||||||||||||||||||||
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
HOW CAN HYPNOTHERAPY SERVE YOU?
| Are you aware that you can begin to make dramatic changes in your life, and discover your sense of well-being right now? You can leave behind depression, anger, grief, insomnia, lack of self-esteem and inner confidence, fears, hopelessness, anxiety, panic attacks, and all kinds of problems in your life right now, through the use of professional hypnotherapy, combined with behavioral therapy. The "conscious" mind uses only 3-5% of the brain, while the other 97-95% percent may be considered the "subconscious". If you are having trouble overcoming a negative habit, behavior, thought, or emotion, it is most likely because your subconscious is not working with you, but against you. Every action, decision, thought or experience you've ever had is stored within your subconscious mind. Even if you don't have a conscious memory of it, your subconscious does. The subconscious not only keeps records of every moment of your life, but it also shapes your automatic reactions and behaviors to match your past experiences, through conditioning. Any trigger that matches a past experience, may bring up an automatic reaction, that can recreate the original experience. That's why one may repeat certain experiences, even if they do not want to. One might wish for change on the conscious level, but if the subconscious is not cooperating, than much of the effort may be wasted. Hypnotherapy is one way to access the subconscious, its long-term memory, and help eliminate the "records" that no longer serve you. What is hypnosis? The hypnotic state or trance, is a natural human state, that one may experience many times throughout the day. Have you ever driven long distance on a highway, automatically checking the road and attending other memories, or projects, or thoughts in your mind? Have you ever been so absorbed by your thoughts, or a movie, that you momentarily lost track of time or place? If so, you may have been in a hypnotic state or trance. Other examples might include while listening to an intriguing story, or while taking a shower. The door to the subconscious may open up at these times, especially when the state is relaxing. Hypnotherapy can induce this type of state. And the professional hypnotherapist can use this opportunity to facilitate positive life changes and healing. In order to have lasting results, it is most effective if not only the symptoms are treated, but also the root causes, which are often located in the subconscious. Talk therapy addresses the conscious mind only, while hypnotherapy can access the subconscious' vast influence. The non-suggestive, state & federally approved technique I employ, combined with behavioral therapy, helps to eliminate the root cause of an issue, without necessarily re-living the past negative experiences or traumas, and their negative associations. In addition, the client retains full awareness and control. The New York Times states that using the combination of clinical behavioral therapy and clinical hypnotherapy has the highest success rate, because this combination addresses not only the hidden blocks and obstacles in the subconscious mind, but also all the negative daily habits we have, that support the problems we are trying to overcome. Behavioral therapy involves making positive changes in one's everyday life, using specific mental and physical techniques, to help one reach the desired goal. Some simple examples are: changing poor eating habits, adjusting the daily routine, improving communication skills, and eliminating negative self-talk. According to the recent medical research, approximately 70% of all known diseases are psychosomatic, which means that their cause is emotional dis-balance. One's mind, body, and emotions are solely their responsibility, and it may be worthwhile to consider complementary techniques to resolve an issue. Hypnotherapy with behavioral therapy is a powerful combination, that may help clear mental and emotional un-easiness, before it becomes physical dis-ease, or help with an existing medical condition. |
Call now for free consultation with Lena:
(530) 692-0151
toll free 877-570-6260
(530) 692-0151
toll free 877-570-6260
|
| Disclaimer: our services are not intended to diagnose, treat, cure or prevent any disease. Individual results may vary. |
Think: how often do you go for a tune-up of your car (before the engine fails)? Do you change oil and air
filter regularly to prevent bigger problems with your car's engine?
Your health is more in your hands when you think in terms of PREVENTION!
For example, here is some information from a recent article in San Francisco Chronicle, that forces one to
think more in terms of prevention:
"The costs of bringing a new drug to market are hotly debated. A Tufts University study estimated $802 million; the
consumer group Public Citizen pegs it at $110 million. Either way, the investment is huge.
By 1990, according to the Infectious Diseases Society of America, half the major drugmakers in Japan
and the United States had cut back or halted antibiotic research. Since 2000, some of the biggest names
in pharmaceutical development - Roche, Bristol-Myers Squibb, Abbott Laboratories, Eli Lilly, Aventis and
Procter & Gamble - had joined the exodus.
By common measures used to gauge the profit potential of new drugs, antibiotics fall way behind.
For every $100 million that a new antibiotic might yield, after projected revenue and expenses are tallied,
a new cancer drug will generate $300 million. A new drug for arthritis, by this same analysis, brings in $1.1 billion. Investors
have been placing their bets accordingly.
Rice, a professor at Cleveland's Case Western Reserve University, said doctors and drug companies alike are responsible
for breeding resistance (of the bacteria) by "the indiscriminate dumping of antibiotics into our human patients."
Drug-resistant germs contaminate the bedrails, the catheter lines, the blood pressure cuffs and even
the unwashed hands of doctors, nurses and orderlies. The germs keep evolving, swapping drug-resistance traits with
other microbes. He likened American intensive-care units - the high-tech enclaves where the most seriously ill patients are
treated - to "toxic waste dumps."
"The federal Centers for Disease Control and Prevention estimates that each year 99,000 Americans die of various
bacterial infections that they pick up while hospitalized - more than double the number killed every year in automobile
accidents.
The costs of bringing a new drug to market are hotly debated. A Tufts University study estimated $802 million; the consumer
group Public Citizen pegs it at $110 million. Either way, the investment is huge.
By 1990, according to the Infectious Diseases Society of America, half the major drugmakers in Japan
and the United States had cut back or halted antibiotic research. Since 2000, some of the biggest names
in pharmaceutical development - Roche, Bristol-Myers Squibb, Abbott Laboratories, Eli Lilly, Aventis and
Procter & Gamble - had joined the exodus.
By common measures used to gauge the profit potential of new drugs, antibiotics fall way behind.
For every $100 million that a new antibiotic might yield, after projected revenue and expenses are tallied,
a new cancer drug will generate $300 million. A new drug for arthritis, by this same analysis, brings in $1.1 billion. Investors
have been placing their bets accordingly.
Rice, a professor at Cleveland's Case Western Reserve University, said doctors and drug companies alike are responsible
for breeding resistance (of the bacteria) by "the indiscriminate dumping of antibiotics into our human patients."
Drug-resistant germs contaminate the bedrails, the catheter lines, the blood pressure cuffs and even
the unwashed hands of doctors, nurses and orderlies. The germs keep evolving, swapping drug-resistance traits with
other microbes. He likened American intensive-care units - the high-tech enclaves where the most seriously ill patients are
treated - to "toxic waste dumps."
From: "Bacteria race ahead of drugs. Falling behind: Deadly infections increasingly able to beat antibiotics."
article by Sabin Russell, Chronicle Medical Writer
Sunday, January 20, 2008San Francisco Chronicle
filter regularly to prevent bigger problems with your car's engine?
Your health is more in your hands when you think in terms of PREVENTION!
For example, here is some information from a recent article in San Francisco Chronicle, that forces one to
think more in terms of prevention:
"The costs of bringing a new drug to market are hotly debated. A Tufts University study estimated $802 million; the
consumer group Public Citizen pegs it at $110 million. Either way, the investment is huge.
By 1990, according to the Infectious Diseases Society of America, half the major drugmakers in Japan
and the United States had cut back or halted antibiotic research. Since 2000, some of the biggest names
in pharmaceutical development - Roche, Bristol-Myers Squibb, Abbott Laboratories, Eli Lilly, Aventis and
Procter & Gamble - had joined the exodus.
By common measures used to gauge the profit potential of new drugs, antibiotics fall way behind.
For every $100 million that a new antibiotic might yield, after projected revenue and expenses are tallied,
a new cancer drug will generate $300 million. A new drug for arthritis, by this same analysis, brings in $1.1 billion. Investors
have been placing their bets accordingly.
Rice, a professor at Cleveland's Case Western Reserve University, said doctors and drug companies alike are responsible
for breeding resistance (of the bacteria) by "the indiscriminate dumping of antibiotics into our human patients."
Drug-resistant germs contaminate the bedrails, the catheter lines, the blood pressure cuffs and even
the unwashed hands of doctors, nurses and orderlies. The germs keep evolving, swapping drug-resistance traits with
other microbes. He likened American intensive-care units - the high-tech enclaves where the most seriously ill patients are
treated - to "toxic waste dumps."
"The federal Centers for Disease Control and Prevention estimates that each year 99,000 Americans die of various
bacterial infections that they pick up while hospitalized - more than double the number killed every year in automobile
accidents.
The costs of bringing a new drug to market are hotly debated. A Tufts University study estimated $802 million; the consumer
group Public Citizen pegs it at $110 million. Either way, the investment is huge.
By 1990, according to the Infectious Diseases Society of America, half the major drugmakers in Japan
and the United States had cut back or halted antibiotic research. Since 2000, some of the biggest names
in pharmaceutical development - Roche, Bristol-Myers Squibb, Abbott Laboratories, Eli Lilly, Aventis and
Procter & Gamble - had joined the exodus.
By common measures used to gauge the profit potential of new drugs, antibiotics fall way behind.
For every $100 million that a new antibiotic might yield, after projected revenue and expenses are tallied,
a new cancer drug will generate $300 million. A new drug for arthritis, by this same analysis, brings in $1.1 billion. Investors
have been placing their bets accordingly.
Rice, a professor at Cleveland's Case Western Reserve University, said doctors and drug companies alike are responsible
for breeding resistance (of the bacteria) by "the indiscriminate dumping of antibiotics into our human patients."
Drug-resistant germs contaminate the bedrails, the catheter lines, the blood pressure cuffs and even
the unwashed hands of doctors, nurses and orderlies. The germs keep evolving, swapping drug-resistance traits with
other microbes. He likened American intensive-care units - the high-tech enclaves where the most seriously ill patients are
treated - to "toxic waste dumps."
From: "Bacteria race ahead of drugs. Falling behind: Deadly infections increasingly able to beat antibiotics."
article by Sabin Russell, Chronicle Medical Writer
Sunday, January 20, 2008San Francisco Chronicle